These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21466414)

  • 41. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
    Yakubu R; Peh KK; Tan YT
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microporous bilayer osmotic tablet for colon-specific delivery.
    Chaudhary A; Tiwari N; Jain V; Singh R
    Eur J Pharm Biopharm; 2011 May; 78(1):134-40. PubMed ID: 21255646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D; Survase S; Kumar N
    Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of membrane composition on release of model hydrophilic compound from osmotic delivery systems.
    Ozdemir N; Ozalp Y; Ozkan Y
    Acta Pol Pharm; 2000; 57(3):181-6. PubMed ID: 11143706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
    Chansanroj K; Betz G
    Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
    Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
    Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, in vitro and in vivo evaluation of glipizide Eudragit microparticles.
    Madhusudhan S; Panda AK; Parimalakrishnan S; Manavalan R; Manna PK
    J Microencapsul; 2010; 27(4):281-91. PubMed ID: 20515261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
    Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
    Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Applicability of a natural swelling matrix as the propellant of osmotic pump tablets].
    Wu L; Li HY; Yin XZ; Li Y; Chen JX; Hu RF; Zhang JW
    Yao Xue Xue Bao; 2013 Aug; 48(8):1319-24. PubMed ID: 24187843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin.
    Rajab M; Jouma M; Neubert RH; Dittgen M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):879-85. PubMed ID: 23607725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microstructural investigation to the controlled release kinetics of monolith osmotic pump tablets via synchrotron radiation X-ray microtomography.
    Li H; Yin X; Ji J; Sun L; Shao Q; York P; Xiao T; He Y; Zhang J
    Int J Pharm; 2012 May; 427(2):270-5. PubMed ID: 22366382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
    Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
    Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
    Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
    J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.